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Renal hypertrophy in experimental diabetes mellitus
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More than 20 years ago it was observed that children with
diabetes mellitus had an increased GFR as compared to normal
children [1]. During the last decade, much evidence has accu-
mulated concerning the kidney in early diabetes mellitus, both
clinical [2, 3] and experimental. Also, the existence of a diabetic
renal hypertrophy and hyperfunction is now well established.
This phenomenon has mainly been studied by investigators of
diabetes who have been puzzled by the apparent paradox that
early diabetes mellitus induces a supranormal state of kidney
function, while the same disease may later lead to renal
insufficiency and uremia. However, diabetic renal hypertrophy
may also interest physiologists as another model for rapid renal
growth, in some ways similar to, but in other ways different
from, the classical compensatory renal hypertrophy following
surgical extirpation of tissue. In this review, the current knowl-
edge of kidney growth as observed in the diabetic rat is
summarized. Firstly, the phenomenon is described according to
biochemical, morphological and functional investigations. Sec-
ondly, various studies concerning possible mechanisms behind
the renal hypertrophy are reviewed; and finally, comparisons
between diabetic hypertrophy and compensatory renal hyper-
trophy will be made.
Induction of experimental diabetes mellitus in the rat by
streptozotocin or alloxan leads to a marked increase in renal
weight beginning only a few hours after the appearance of
hyperglycemia and glycosuria [4]. The weight increase can be
seen regularly 72 hr after the injection of streptozotocin, that is,
about 60 hr after the onset of diabetes mellitus. The lag-time can
be shortened somewhat by treating the rats with insulin for the
first few days after streptozotocin. In this situation there are no
measurable changes in the kidney immediately on the cessation
of insulin treatment, but 36 hr later there is a significant increase
in renal weight. The reason for this acceleration of kidney
growth is probably that streptozotocin leads acutely to anorexia
and weight loss for 2 to 3 days. These systemic effects of the
drug counteract the growth-promoting effects of diabetes melli-
tus at the very beginning of the experiment. When insulin is
given, diabetes mellitus starts to exert its influence at a time
when appetite is restored and the animal is fully responsive.
The renal weight gain continues for several weeks but gradu-
ally tapers off. Typically, kidney weight increases by 15 to 20%
3 days after streptozotocin, and by 70 to 90% after 6 weeks.
It should be mentioned in this connection that kidney weight
in other experimental situations (e.g., compensatory renal
hypertrophy following unilateral nephrectomy) is given often as
weight per unit of body weight. In diabetes mellitus there is an
inevitable loss of body weight, and thus, kidney weight is
overestimated by the use of such a correction. It is preferable to
use groups of animals of equal body weight at the beginning of
the experiments. Furthermore outgrown rats whose kidney
weight has plateaued should be used for experiments lasting
longer than a few days. This can be achieved by using female
rats more than 5 months old.
Diabetic kidney growth is not due to an accumulation of
water. The water concentration of the kidneys is constant, and
the protein content rises in parallel to the weight [4]. The
diabetic kidney grows by an admixture of cellular hypertrophy
and hyperplasia. The first sign of growth is an increase in RNA
content that is measurable 24 hr after the onset of glycosuria. At
about the same time the cellular pools of RNA precursors and
the incorporation of orotate into UTP are increased [5]. Shortly
thereafter, an increase in the protein/DNA ratio can be mea-
sured, indicating hypertrophy of the cells. DNA accretion is,
however, seen only after 1 week, and from that time on
hyperplasia accounts for the major part of renal growth so that
after 6 weeks of diabetes mellitus the kidney has almost doubled
its weight, the average cell size has increased by about 25%,
and the number of cells by about 50% [4].
Renal hypertrophy in diabetes is influenced markedly by the
metabolic state of the experimental animal. In less severe
diabetes mellitus, that is, when blood glucose concentrations
range from normal to about 18 mmoles/liter, kidney weight after
7 days of diabetes is correlated linearly to blood glucose with a
correlation coefficient of about 0.8 [61. On the other hand, a
severe diabetic state with blood glucose concentrations above
25 mmoles/liter inhibits renal hypertrophy. This is probably due
to the severe catabolism seen under these conditions, as kidney
weight is related inversely to loss in body weight [7]. Therefore,
the optimal conditions for the study of renal hypertrophy in
diabetes mellitus comprise a blood glucose concentration above
15 mmoles/liter and a minimal loss of body weight. Several
authors have reported explicitly that kidney size is normal or
even reduced in diabetes mellitus, simply because they have
studied severely ill animals.
The morphological features of the hypertrophying diabetic
kidney have been studied both by light and electron microsco-
py. Using stereological methods, we measured the size of
various substructures of the rat kidney at intervals after the
induction of diabetes [81. After 4 days of diabetes mellitus the
total glomerular volume (and thus the average glomerular
volume) increases by 30%, but after that time, little further
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increase is seen. Proximal tubules, on the other hand, which
constitute the greater part of the kidney, grow more slowly, but
also more persistently. After 4 days the increase in tubular
epithelial cell height is maximal, and after that time the tubules
grow by increasing their length and diameter. Morphometry of
the distal tubules have been difficult to perform, because
glycogen accumulation after a few weeks of diabetes prevents
exact measurements (the Armanni-Ebstein lesion).
Diabetic renal hypertrophy thus is non-uniform in its early
stages, presenting an anatomical glomerulotubular imbalance.
Whether this phenomenon is also reflected functionally is at
present unknown. After a few weeks of diabetes mellitus the
relation between glomerular and tubular size has returned to
almost nondiabetic levels.
The vascular anatomy of the glomerulus in diabetes rnellitus
has been studied stereologically by electron microscopy [91. In
parallel to the heterogenous growth of the whole kidney intra-
glomerular structures also expand in a non-uniform manner
during the earliest stages of diabetes mellitus. Thus, after4 days
of diabetes the total length of the glomerular capillaries within
the kidney has increased by 30%, while the average cross-
sectional area of the capillaries is unchanged. Six weeks later,
however, capillary length is equal to that seen in nondiabetic
rats, whereas the cross-sectional area by now has increased by
30%. This means that the filtration surface of the glomeruli
increases rapidly, but later decreases a little, whereas flow
resistance caused by the capillary geometry (arteriolar resist-
ance not taken into account) primarily increases and later
decreases to values below those seen in nondiabetic rats. When
the filtration surface is determined by measurement of the
glomerular basement membrane surface, a total area of 120 cm2!
kidney in nondiabetic rats increases to 170 cm2 after 4 days and
146 cm2 after 6 weeks of diabetes. The implications of the
findings for the glomerular function are difficult to assess
because of several other factors, which determine glomerular
filtration rate. One thing is clear, however: In very early
experimental diabetes, the filtration surface enlarges faster than
the glomerulus, and the glomerulus enlarges faster than the
whole kidney, but after some time there is a renewed balance
between filtration surface area, glomerular volume, and kidney
volume. It should be emphasized that glomerular enlargement
in diabetes has also been found by other methods (differential
sieving) [10], and therefore cannot be explained by technical
errors in the preparation of the kidneys for stereological
examination.
Several investigators have studied whole kidney function in
the diabetic rat. Hostetter, Troy, and Brenner [11] found a 33%
increase in GFR in streptozotocin diabetic animals treated with
insulin to achieve a moderate degree of hyperglycemia and
normal weight gain, whereas GFR in severely diabetic rats was
33% lower than in controls. In the moderately diabetic group
kidney weight increased, so that GFRIg kidney equalled that of
controls, whereas kidney weight in the severely diabetic group
was similar to that of controls, meaning that GFR/g kidney was
decreased significantly in these animals. Michels, Davidman,
and Keane [12] made essentially the same findings, that is, GFR
rose proportionally to kidney weight in insulin-treated diabetic
rats, but GFRIg kidney weight decreased in severe diabetes.
Jensen et al 1131 found GFR to increase somewhat more than
kidney weight during diabetic renal hypertrophy.
In all three studies the rats were examined after several
weeks of diabetes mellitus, when the kidney may he assumed to
have reached a new steady state. The evolution of the glomeru-
lar hyperfunction was studied by Carney, Wong, and Dirks [141,
who examined streptozotocin diabetic rats during the first 8
days after the induction of diabetes. They found GFR increased
by 23% on day 8 (the authors state that significantly increased
GFR was found on day 4 already, but this is only the fact, when
GFR is calculated per gram of body weight). These authors
found no increase in kidney weight after 8 days of diabetes, and
thus GFRi'g kidney weight increased greatly during the initial
phase of diabetes mellitus. In another study (Seyer-Hansen,
unpublished) GFR measured in unanesthetized rats was un-
changed after 4 days of diabetes, when kidney weight had
increased by 14%. After 10 days GFR had barely increased
significantly, while kidney weight was 24% higher than in
controls. Only after 28 days GFR was increased to the same
extent as kidney weight (about 30%). Thus, there is a disturbed
renal anatomico-functional balance in the early stages of diabe-
tes, a disturbance which appears even greater, when it is
remembered that glomerular volume increases very rapidly
during the first few days of diabetes mellitus.
Very little is known about tubular function in experimental
diabetes mellitus. Carney, Wong, and Dirks [14] in the study
cited above measured the reabsorption of glucose and sodium,
as well as that of other cations, and found no consistent changes
in fractional sodium excretion, indicating a preserved glomer-
ulo-tubular balance. It is remarkable that they found glucose
reabsorption to be almost complete in rats with a blood glucose
concentration above 300 mg!dl, that is, rats with moderate to
severe diabetes mellitus showed almost no glycosuria. This
strongly contrasts to common experience and makes it difficult
to draw general conclusions from their study.
Micropuncture studies with measurements of determinants of
glomerular filtration have been performed by three groups of
authors [11—13] with slightly different results, probably because
of differences in animal strains and experimental techniques.
All three groups, however, agree that in rats with moderate
diabetes of some weeks duration SNGFR is increased propor-
tionally to kidney weight and that increased glomerular plasma
flow is the major determinant for this. Furthermore, none of the
authors finds significant changes in the glomerular ultrafiltra-
tion coefficient. This last result is difficult to relate to the fact
that diabetic rats have enlarged glomerular filtration surface,
especially because all authors found filtration disequilibrium in
diabetic rats. The results may indicate a decreased hydraulic
permeability of the filtration barrier in diabetes. The finding of
elevated SNGPF correlates well with the finding of dilated
glomerular capillaries in morphometric studies. It must, howev-
er, be emphasized that there are no reports of functional and
morphological studies perfOrmed in the same animals. No
micropuncture studies have been done in very early diabetes.
The mechanisms behind the renal hypertrophy and hyper-
function in diabetes remain obscure. The condition is not
caused by the betacytotoxic agents used to induce diabetes,
because insulin treatment started at the onset of hyperglycemia
prevents kidney growth 141. Similarly Cortes et al [51 have
shown that insulin infusion prevents the increased incorpo-
ration of orotate into cortical RNA seen in very early diabetes.
When insulin is started after some weeks of diabetes. there is no
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Table 1. Study A: Rats studied 20 days after nephrectomy or
streptozotocin [7]
Nephrectomy Diabetes
Kidney weight +39% +28%
RNA content +24% +16%
DNA content +21% +10%
Protein/DNA +23% +25%
significant decrease in kidney weight, RNA, or DNA content,
even after 2 weeks of insulin [4]. This is, however, probably due
to the fact that normoglycemia is difficult to achieve in rats by
conventional insulin treatment once the diabetic state is estab-
lished. GØtzsche, Gundersen, and Østerby [151 used islet trans-
plantation to obtain a normal blood glucose in rats diabetic for 4
weeks, and they found a significant decrease in kidney weight
and a normalization of the RNA/DNA ratio after 4 weeks.
Diabetic renal hypertrophy thus is at least partly reversible.
As mentioned above, there is a close correlation between the
blood glucose level and the rate of kidney growth [7]. Plasma
glucagon is elevated in diabetes, and as Cortes et al [16] have
shown, orotate incorporation into glomerular DNA correlates
with the plasma glucagon levels. Furthermore, orotate incorpo-
ration is inhibited by infusion of insulin in doses so small that
plasma glucose is unchanged, but plasma glucagon is lowered.
The addition of glucagon to the infusion again increases orotate
incorporation. Accordingly, it has been suggested, that hyper-
glucagonemia is the major causative factor for the kidney
growth. Studies, in which glucagon has been infused to nondia-
betic animals, are, however, lacking, so the role of glucagon has
not been proven. Growth hormone increases GFR in clinical
studies. We gave growth hormone to rats in biologically potent
doses for 4 days but found no increase in kidney weight or
content of nucleic acids [17]. Neither did growth hormone
accentuate kidney growth in diabetic rats.
In view of the marked hemodynamic changes in the diabetic
kidney, it has been suggested [111 that vasoactive substances
such as prostaglandins or catecholamines might be of impor-
tance for the renal response to diabetes. I have not found an
inhibition of renal hypertrophy from propranolol or indometh-
acm (unpublished observations). Furthermore, it is unlikely
that the hemodynamic changes are primary to the structural
changes, as renal growth and glomerular expansion are demon-
strable before any changes in GFR (Seyer-Hansen, unpublished
data). It is generally agreed that the once popular hypothesis of
workload hypertrophy after unilateral nephrectomy has been
refuted. Diabetes mellitus may be different in this connection.
There, in fact, is a considerably increased energy consumption
in the diabetic kidney, namely for glucose reabsorption and
gluconeogenesis. It remains to be shown whether one or both of
these two processes can trigger renal growth.
The classical model for the study of renal growth is the
compensatory hypertrophy seen after unilateral nephrectomy.
There are several other ways of producing renal hypertrophy
(high protein diet, cold exposure, ammonium chloride adminis-
tration, folic acid, and so forth), but none of these have been as
extensively studied as that following unilateral nephrectomy. It
is therefore natural to compare this old and established phe-
nomenon to the relative new one of diabetic renal hypertrophy.
Table 2. Study B: Rats studied 24 days after nephrectomy or
streptozotocin ([8, 91 and Seyer-Hansen, Gundersen, and Østerby,
unpublished data)
Nephrectomy Diabetes
Kidney weight +50% +53%
Glomerular volume +27% +38%
Proximal tubular length + 15% +9%
Proximal tubular diameter + 10% +21%
It is difficult to compare data taken from various parts of the
numerous literature because of differences in technical proce-
dures and animal strains used by different authors. There are,
however, a few studies, in which the same authors examined
diabetic and nephrectomized rats of the same strains with the
same methods, either in simultaneous experiments or at differ-
ent times. These studies mostly concern animals studied some
weeks after the induction of renal growth, when the hypertro-
phy is well established, and a new steady state of the kidney
may be assumed to exist. Some of the principal findings of these
investigations are shown in Tables 1 to 3, where the percentage
increase in various renal variables has been calculated from the
original papers.
From study A (Table 1) it seems that cellular hyperplasia
plays a relatively greater role for compensatory renal growth
than for diabetic growth, but it may be due to the fact that total
growth was more pronounced after nephrectomy than after
streptozotocin in this study.
In study B (Table 2) total kidney weight was the same in the
two groups. However, the glomerular fraction of the kidney
was somewhat larger in diabetes. This finding is corroborated
by similar studies done 4 days after nephrectomy or streptozo-
tocin, and probably represents a real difference.
From study C (Table 3) it appears that the elevated glomeru-
lar plasma flow in diabetes bears less influence on SNGFR than
in the nephrectomy situation. However, in the papers in which
filtration fraction was cited, it was not significantly different
from that of control rats in either nephrectomized or diabetic
rats. The overall picture denotes a great similarity between the
two types of enlarged kidneys, once the kidney growth has
plateaued. However, there may be great differences in the mode
of renal hypertrophy in diabetes and after nephrectomy in the
initial stages of the process. Thus, we found the glomerular
fraction of the kidney to increase by 10% after 4 days of
diabetes mellitus but to decrease by 10% 4 days after nephrecto-
my despite equal increase in total kidney weight [8]. Glomerular
filtration rate in compensatory renal hypertrophy has been
reported either to increase before any measurable renal growth
[19] or to lag behind [201. Following what was stated previously,
kidney function in diabetes mellitus appears to increase only
after the kidney weight has increased. Very early biochemical
changes can be detected in the remaining kidney after unilateral
nephrectomy, perhaps as early as a few minutes after the
operation. No similar studies have been performed in diabetes.
Thus, a large amount of investigation remains to be made
before diabetic renal hypertrophy is as well characterized as
compensatory hypertrophy. The latter condition has been stud-
ied extensively for about 30 years, whereas the former one has
been known for only 20 years and studied systematically only
by a few groups during the last decade. Finally, a few comments
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Table 3. Study C: Rats studied 2 to 15 weeks after nephrectomy or
streptozotocin [11, 181
Nephrectomy Diabetes
Kidney weight +48% +31%
GFR +50% +34%
SNGFR +84% +43%
SNGPF +79% +71%
Hydrostatic filtration
pressure gradient + 18% +22%
should be made about the combination of diabetes rnellitus and
nephrectomy. When streptozotocin is given and nephrectomy is
performed at the same time, the effect is a very rapid increase in
kidney size [81. After 5 days kidney weight rises by 47%
compared to 20% after either single procedure. Even more
impressive is the outcome of nephrectomy performed in an
animal which has been diabetic for some weeks. The operation
now induces a more than 40% kidney weight increase in 5 days,
meaning that the stimulus of nephrectomy has more than twice
the effect on a diabetic kidney than on a normal kidney. If the
sequence of stimuli is reversed, that is, if diabetes mellitus is
induced in an animal nephrectomized some weeks earlier,
exactly the same is seen. It is difficult to explain why the
hypertrophied kidney is sensitized to further stimuli in this
manner. Whatever its cause may be, this phenomenon which
has been very little investigated, might be a useful model for the
study of very rapid renal growth. Hitherto subtotal (that is,
three-quarters to five-sixths), nephrectomy has been used for
this purpose, but the diabetic and nephrectomized rat could
have some advantages, particularly because a reduction in
kidney function is avoided.
Summary. The kidney changes seen in rats shortly after the
induction of experimental diabetes were reviewed: Kidney
weight increases by 15 to 20% during the first 4 to 5 days of
diabetes and by 70 to 90% after some weeks. GFR increases
after a lag-time of some days in parallel to kidney weight.
Morphometric analysis shows glomerular hypertrophy to be
prominent during the first few days of diabetes. The glomerular
filtration surface increases by 40% after 4 days. Diabetic renal
hypertrophy is related to the severity of the diabetes, and
kidney growth rate relates linearly to blood glucose. Moderate
diabetes mellitus and unilateral nephrectomy have approxi-
mately the same effect on the kidney (weight increase 20%/4
days). When diabetes mellitus and nephrectomy are combined,
renal growth rate almost doubles.
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